Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

amylyx.com

Amylyx is a biopharmaceutical company focused on developing treatments for progressive neurodegenerative diseases. Its lead therapy, AMX0035 (marketed as Relyvrio), is a combination treatment for ALS designed to protect neurons by targeting mitochondrial and endoplasmic reticulum dysfunction. Amylyx advances a pipeline testing similar neuroprotective approaches in other neurological disorders and runs clinical trials to generate patient-centered evidence. The company emphasizes translational research, regulatory engagement, and partnerships with patients and clinicians to bring new therapies to market.

ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

© All Rights Reserved. ApplyBlast.com